---
authors:
- Hull, Megan L
- Adelman, Megan
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/40531156/
file_path: 2025/06/lecanemab-leqembi-for-the-slowing-of-alzheimer-disease.md
issue: '6'
last_updated: '2025-07-30'
original_format: PubMed
pages: 549-550
patient_population: Adults
peer_reviewed: true
pmid: '40531156'
processed_date: '2025-07-30'
publication_date: '2025-06-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Lecanemab (Leqembi) for the Slowing of Alzheimer Disease.
topics:
- Family Medicine
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '40531156'
  title: Lecanemab (Leqembi) for the Slowing of Alzheimer Disease.
  authors:
  - last_name: Hull
    fore_name: Megan L
    initials: ML
    affiliation: OhioHealth Grant Family Medicine, Columbus.
  - last_name: Adelman
    fore_name: Megan
    initials: M
    affiliation: Cleveland Clinic Akron General Center for Family Medicine, Akron,
      Ohio.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '6'
  publication_info:
    year: '2025'
    month: '06'
    full_date: '2025-06-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '40531156'
  title: Lecanemab (Leqembi) for the Slowing of Alzheimer Disease.
  authors:
  - name: Hull ML
    authtype: Author
    clusterid: ''
  - name: Adelman M
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2025 Jun
- pmid: '37676096'
  title: Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease.
  authors:
  - name: Kurkinen M
    authtype: Author
    clusterid: ''
  source: Adv Clin Exp Med
  pubdate: 2023 Sep
- pmid: '36757347'
  title: Lecanemab (Leqembi) for Alzheimer's disease.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2023 Feb 6
- pmid: '37651294'
  title: Lecanemab (Leqembi) granted full approval for early Alzheimer's disease.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2023 Aug 21
- pmid: '38484190'
  title: Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer
    Disease.
  authors:
  - name: Nguyen HV
    authtype: Author
    clusterid: ''
  - name: Mital S
    authtype: Author
    clusterid: ''
  - name: Knopman DS
    authtype: Author
    clusterid: ''
  - name: Alexander GC
    authtype: Author
    clusterid: ''
  source: Neurology
  pubdate: 2024 Apr 9
---

# Lecanemab (Leqembi) for the Slowing of Alzheimer Disease.

**Authors:** Hull, Megan L, Adelman, Megan

**Published in:** American family physician | Vol. 111, No. 6 | 2025-06-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/40531156/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/40531156/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
